Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.90
Bid: 7.80
Ask: 8.00
Change: 0.00 (0.00%)
Spread: 0.20 (2.564%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 7.90
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Lucyd Distribution Growth

29 Sep 2021 14:17

RNS Number : 4197N
Tekcapital plc
29 September 2021
 

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

 

29 September 2021

Tekcapital Plc

("Tekcapital", the "Company" or the "Group")

Portfolio Company Update: Lucyd Ltd ("Lucyd")

Retail Distribution Growth

 

Tekcapital Plc (AIM: TEK, OTCQB: TEKCF), the UK intellectual property investment group focused on transforming university discoveries into valuable products to improve quality of life, is pleased to announce that portfolio company Lucyd's U.S. operating subsidiary, Innovative Eyewear, Inc., has added 21 retail optical stores to its customer base as a result of its recent participation at Vision Expo West.

 

As a result of its attendance at the Expo, the total retail store count carrying Lucyd frames has grown to 85 direct retailers, in addition to 31 indirect retailers in Canada via Lucyd's distribution agreement with Marca Eyewear's 8 Points Inc. subsidiary.

 

Lucyd's goal is to have its eyewear carried in stores across North America and Europe by the end of 2022, and it is aggressively expanding its footprint, by improving its optician-centric business practices, and through the introduction of a co-op marketing program.

 

Significant interest has been expressed by customers and optical businesses for the six new styles of Lucyd Lyte launched this month, and Lucyd is planning to expand brand awareness with the introduction of virtual try-on kiosks in retail stores, to facilitate customer education and product sell-through. These kiosks will be remotely updated to reflect new style additions to the Lucyd product line, and refreshed regularly with new video content. The kiosk will allow for a sterile, touch-free shopping experience, as it runs through an automatic cycle of superimposing all Lucyd frames to the viewer's face in a virtual mirror, as opposed to traditional eyewear shopping where a customer touches and wears a number of different frames that have been handled by the public.

 

Harrison Gross, Lucyd cofounder and CEO said, "We are very excited to report the rapid growth of our optical store customers and look forward to additional new product launches and other developments in 2021. Not only are we offering groundbreaking smart eyewear, we are offering innovative merchandising support through a co-op marketing plan focused on the forthcoming try-on kiosk."

 

About Lucyd and Innovative Eyewear Inc.

Lucyd's mission is to Upgrade your Eyewear® with advanced ergonomic frames that are easy to use, fun to wear, and help you stay safely connected to your digital life. The Lucyd brand and IP portfolio are exclusively licensed to and operated by Innovative Eyewear, Inc. To learn more, or order Lucyd Lyte, please visit https://lucyd.co

 

Tekcapital currently owns 100% of the share capital of Lucyd Ltd and approximately 81% of the share capital of its U.S. operating subsidiary, Innovative Eyewear, Inc.

For further information, please contact:

 

Tekcapital Plc 

Via Flagstaff

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP

(Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison/Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

Flagstaff Strategic and Investor Communications

+44 (0) 20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

LEI: 213800GOJTOV19FIFZ85

Forward-Looking Statements

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Lucyd or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Tekcapital or Lucyd's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Lucyd and/or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither Lucyd nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEADNNAEPFEFA
Date   Source Headline
18th Aug 20227:00 amRNSLucyd Portfolio Company Update
18th Aug 20227:00 amRNSInnovative Eyewear Inc. Closing of US $ 7.35 M IPO
15th Aug 20227:00 amRNSLucyd -Pricing of US$ 7.35 Million IPO
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSHalf Year Report for period ending 31 May 2022
21st Jul 20224:40 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20224:41 pmRNSSecond Price Monitoring Extn
4th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSSalarius First U.S.A. Bulk B2B Order
16th Jun 20229:55 amRNSGrant of Share Options
15th Jun 20222:42 pmRNSNotification of Major Holdings
7th Jun 20227:00 amRNSNotification of Major Holdings
1st Jun 20223:08 pmRNSNotification of Major Holdings
31st May 20222:30 pmRNSResult of AGM
30th May 20227:00 amRNSPortfolio Company Update :Salarius
25th May 20221:19 pmRNSTR-1: Notification of major holdings
25th May 20227:00 amRNSPlacing to Raise £2 Million (c.US$ 2.5M)
6th May 202211:36 amRNSNotice of AGM
6th May 20227:00 amRNSFinal Year End Record Results
5th May 20227:00 amRNSGuident Update
3rd May 20228:35 amRNSGuident Update
19th Apr 20227:00 amRNSPortfolio Company Update - Guident
1st Apr 20227:00 amRNSPortfolio Company Update - Salarius
25th Mar 202211:39 amRNSNotification of Major Holdings
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSSalarius Update
11th Feb 20225:58 pmRNSExercise of Stock Options and Total Voting Rights
11th Feb 20222:06 pmRNSSecond Price Monitoring Extn
11th Feb 20222:00 pmRNSPrice Monitoring Extension
11th Feb 202211:06 amRNSSecond Price Monitoring Extn
11th Feb 202211:01 amRNSPrice Monitoring Extension
4th Feb 20227:00 amRNSGuident Update
2nd Feb 20227:00 amRNSLucyd Expands Ecommerce Channels
4th Jan 20227:00 amRNSSalarius Completes Oversubscribed Crowdfund
29th Dec 20217:00 amRNSSalarius Appoints CEO
24th Dec 20217:00 amRNSSalarius Appoints Non Executive Director
14th Dec 20217:00 amRNSLucyd Filing for United States IPO
9th Dec 20217:00 amRNSSalarius Update
22nd Nov 202112:09 pmRNSHolding(s) in Company
16th Nov 20217:00 amRNSSalarius Update
15th Nov 20217:00 amRNSSalarius Update
11th Nov 20217:00 amRNSAppointment of new Auditor
4th Nov 20217:00 amRNSPortfolio Company Update: Lucyd Ltd ("Lucyd")
3rd Nov 20217:00 amRNSPlacing to raise £3.0 million
27th Oct 20217:00 amRNSSalarius Appointment of Chief Medical Officer
26th Oct 20214:40 pmRNSSecond Price Monitoring Extn
26th Oct 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.